Combined modality therapy with TRAIL or agonistic death receptor antibodies - Amm, Hope M.; Oliver, Patsy G.; Lee, Choo Hyung; Li, Yufeng; Buchsbaum, Donald J. (Cancer biology & therapy, 2011)
Keywords: Antibodies, Monoclonal - therapeutic use; Antineoplastic Agents - metabolism; Antineoplastic Agents - therapeutic use; Apoptosis; Binding; Biology; Bioscience; Calcium; Cancer; Cell; Combined Modality Therapy; Cycle; Humans; Landes; Molecular Targeted Therapy; Neoplasms - drug therapy; Neoplasms - metabolism; Organogenesis; Proteins; Receptors, TNF-Related Apoptosis-Inducing Ligand - agonists; Receptors, TNF-Related Apoptosis-Inducing Ligand - immunology; Receptors, TNF-Related Apoptosis-Inducing Ligand - metabolism; Review; Signal Transduction - drug effects; TNF-Related Apoptosis-Inducing Ligand - metabolism; TNF-Related Apoptosis-Inducing Ligand - therapeutic use